The affinity of MAX for the E-Box sequences containing different cytosine modifications as determined by EMSAs 6 . In the case of mC:mC and hmC:hmC only weak / non-specific binding was observed as evidenced by a slight reduction of free probe but no formation of a distinct complex. (nd: not determined) (D) Competition of a radiolabeled unmodified E-Box-USF complex with unlabeled probes containing different modifications. The central CpG modification state is given above the lanes. Supplementary Table S2 . Crystallographic data collection, processing and structure refinement statistics.
*Note: The high redundancy data for the 5mC structure contributes to the exaggerated high Rmeas in the high resolution bin -the I/σI value in this case is a more reasonable measure of the data quality.
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Additional background information
Crystallographic investigations of B-DNA reveal high similarity between C and 5mC duplexes, with methylation causing slight minor groove compaction 11 . Structures of 5mC in , but the relatively low resolution (2.4 Å) and presence of protein, does not enable analysis of the effect of 5hmC on isolated dsDNA structure.
Supplementary Methods
Oligonucleotide synthesis, purification and analysis
Standard DNA phosphoramidites, solid supports and additional reagents were purchased from Link Technologies and Applied Biosystems Ltd. Oligonucleotides were synthesized using an Applied Biosystems 394 automated DNA/ RNA synthesizer using a standard 1.0 mole phosphoramidite cycle of acid-catalyzed detritylation, coupling, capping, and iodine oxidation. Stepwise coupling efficiencies and overall yields were determined by an automated trityl cation conductivity monitoring facility and in all cases were >98.0%. -Cyanoethyl phosphoramidite monomers were dissolved in anhydrous acetonitrile to a concentration of 0.1 M immediately prior to use. The coupling time for normal A, G, C, and T monomers was 35 s, and the coupling time for the 5-methyl-2ˊ-deoxycytidine monomer was 60 s and for 5-hydroxmethyl-2ˊ-deoxycytidine monomer (5hmC) it was extended to 360 s. Cleavage of the oligonucleotides from the solid support and deprotection was achieved by exposure to concentrated aqueous ammonia solution (60 min. room temp.) followed by heating in a sealed tube (72 h, 65 °C). The fully deprotected oligonucleotides were purified by reversed-phase HPLC on a Gilson system using a Luna 10 µL C8 100Å pore Phenomenex 10x250 mm column with a gradient of acetonitrile in ammonium acetate (0% to 50% buffer B over 20 min, flow rate 4 mL/min), (buffer A: 0.1 M ammonium acetate, pH 7.0, buffer B: 0.1 M ammonium acetate, pH 7.0, with 50% acetonitrile). Elution was monitored by UV absorption at 295 nm. After HPLC purification, oligonucleotides were desalted using NAP-10 columns (GE Healthcare). The purified oligonucleotides were characterized by mass spectra on a Bruker micrOTOF TM II focus ESI -TOF MS instrument in ES -mode.
Crystallography
Crystals were grown at 20˚C by the hanging drop vapour diffusion method in 24 well Linbro plates using 22mm round cover slips and sealed using vacuum grease using the conditions in Supplementary  Table S1 . Crystals appeared within a few days and were harvested after 1 week. The MPD in the equilibrated drops was sufficient to serve as cryo-protectant and crystals were harvested directly from the crystal growth drop using a nylon loop and plunged into liquid nitrogen to cyro-cool. Crystals were stored under liquid nitrogen until they were mounted on a goniometer at the synchrotron beamline under a nitrogen gas stream at 100K. Complete data sets were collected for single crystals of each modification type and independently indexed, integrated and scaled using Xia2 21 or XDS/SCALA 22 as indicated. The structures were solved by molecular replacement using PHASER 23 and PDB entry 1BNA 24 and refined using PHENIX 25 .
Protein methods
MAX and USF were cloned from isolated cDNA into pGEM-T Easy vectors (Promega) using the following primers MAX_FW: ATGAGCGATAACGATGACATCGAGGTGG, MAX_RW: TTAGCTGGCCTCCATCCGGAGCTTC, USF_FW: ATGAAGGGGCAGCAGAAAACAGCTG, USF_RW: GGCCCAAAGCCCCTGAATCCCCA. MAX was subsequently subcloned into pET15b vector. MAX was expressed in BL21(DE3) Rosetta 2 and purified by IMAC and gel filtration. Plasmids encoding for hypoxic inducible factor (HIF)1-α and HIF1-β were a kind gift from Prof. Christoph W. Pugh. USF and Hif1-α/β were produced by IVTT using the TnT® Coupled Reticulocyte Lysate System (T7 for HIF, SP6 for USF; Promega; L4601 and L4611) using the manufacturer recommended conditions. For the control lanes, the manufacturer supplied luciferase plasmid was added to the IVTT mixture instead of the HIF1-α and -β plasmids.
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EMSA probe preparation
For PCR generated HIF probes using Pfu Ultra (Agilent) substitution mCTP (NEB, N0356S) or hmCTP (bioline, BIO-39046) for CTP using the manufacture recommended conditions. Following template and primers were Oligonucleotides obtained from Sigma (unmodified), Eurofins (mC) or ATDBio (hmC) and resuspended in 10 mM TRIS pH 7.5. Concentrations were determined by measuring the A260 using the nanodrop. Theoretical absorption values and molecular weight were calculated using the webbased IDT oligo analyzer (http://eu.idtdna.com/analyzer/applications/oligoanalyzer/). The probes were annealed at an equimolar ratio (5 µM in 50 µL) in a PCR machine by cooling from 95°C to 4°C at 0.5°C/min. Annealing was confirmed by PAGE gel (15 %, 0.5x TBE; data not shown). After annealing, the concentration was again measured (Nanodrop ND-1000). Probes (50 ng) were phosphorylated using polynucleotide kinase (10 u, NEB, M0201) with ATP, [γ-32 P] (1 µL, Perkin
Elmer, NEG002A250UC) for 30 min at 37°C. Radiolabelled probes were separated from free ATP using the QIAquick Nucleotide Removal Kit (Qiagen, 28304) as described in the manufacture manual.
